Overview
What It Is The ReCODE (Bredesen) Protocol is a personalized, multi-factorial program aimed at identifying and addressing multiple potential contributors to cognitive decline. It involves extensive laboratory testing, cognitive assessment, and lifestyle evaluation, then a plan that typically includes diet, targeted supplements, exercise, sleep optimization, stress reduction, and sometimes additional medical treatments.
How It Works The model treats cognitive decline as the result of a network of metabolic, inflammatory, toxic, and trophic imbalances rather than a single pathway. By addressing those contributors, the program aims to create a biological environment in which remaining neural networks can function better and, potentially, adapt. Any cognitive gains still depend on the brain’s capacity to respond to improved conditions and ongoing healthy activity.
Conditions - Used for: mild cognitive impairment and early Alzheimer’s-type cognitive decline (program-defined subtypes). - Note: Evidence consists mainly of case series and small pilots. Larger independent randomized trials are still limited. Cost and complexity are high; this is not a standard approved disease-modifying drug therapy.
How it is administered
Begins with comprehensive lab testing and cognitive assessment (in-clinic or through partner providers). Follow-up is often remote with coaching. The plan includes diet, exercise, sleep, stress reduction, supplements, and ongoing monitoring.
Conditions connected in the NPA database
The NPA Treatment Database lists this treatment in connection with 3 condition records. A database relationship does not establish effectiveness, safety, or suitability for an individual.
Related questions
These controlled question pages reference this treatment through stored condition relationships.
Symptoms connected in the NPA database
The current record associates this treatment with the following symptom information. This is not a claim that the treatment will improve these symptoms.
Cognition & Memory
- confusion with time/place
- difficulty with familiar tasks
- Later memory and thinking changes
- memory
- Memory loss (especially recent events)
- multitasking difficulty
- Problems with concentration
- slowed mental processing
- slowed thinking
- trouble planning or problem-solving
Emotion & Behavior
- anxiety
- apathy
- Depression
- emotional control issues
- irritability
- Mood and personality changes
- mood changes
- withdrawal from activities
Motor Control
- balance and coordination problems
- balance and gait problems
- Later-stage mobility and coordination decline
- Muscle weakness
- rigidity/stiffness
- slowed movement (bradykinesia)
- stiffness/spasms
- Tremor
- walking difficulty
Sleep & Fatigue
- Extreme fatigue (one of the most common symptoms)
- fatigue
- restlessness at night
- Sleep disturbances
- Sleep problems (including REM sleep behavior disorder)
Practical information
Insurance coverage
Almost never covered by insurance.
Cost information
High. Initial evaluation and testing often $1,000–$3,000+. Ongoing costs (supplements, coaching, follow-ups, optional therapies) commonly $500–$2,000+ per month. Full programs can reach $20,000–$30,000+ per year.
Results and outcomes described in the source record
Some individuals report improvements in energy or clarity within weeks to a few months; cognitive changes are typically assessed over 3–6+ months of consistent adherence.
Side effects and risks
Generally low risk if medically supervised. Cost and complexity are significant practical barriers.
Research context in the NPA database
This section reproduces the current database's research summary and detail. Structured citation metadata has not been supplied, so it should not be read as an independently verified literature review.
Research summary
Evidence Level: Emerging
What the research shows: Small studies and case series report cognitive improvements for some people following a multi-factorial lifestyle and medical protocol. Larger independent trials are still limited, and mainstream guidelines consider the approach investigational.
Key takeaway: An intensive, personalized lifestyle-and-medical program for cognitive decline that requires significant commitment and medical oversight.
Research detail
Overview The ReCODE (or Bredesen) Protocol, offered through Apollo Health and trained practitioners, is a personalized, multi-factorial program aimed at identifying and addressing multiple potential contributors to cognitive decline. It is based on the work of Dr. Dale Bredesen and frames Alzheimer’s and related cognitive loss as the result of a network of metabolic, inflammatory, toxic, and trophic imbalances rather than a single disease process. Participants undergo extensive laboratory testing, cognitive assessment, and lifestyle evaluation.
Evidence Base and Published Work • Evidence consists mainly of case series and small pilot studies reporting cognitive improvements in some participants following a multi-factorial lifestyle and medical protocol. • Larger independent randomized controlled trials remain limited, and larger independent randomized trials are still limited. • Key published work includes: – Bredesen DE and colleagues’ case series and small pilot studies reporting cognitive improvements. – Related papers describing the multi-factorial model and subtype classification of cognitive decline. – The protocol requires extensive laboratory testing, dietary change, supplements, and ongoing medical oversight. Cost and complexity are high; individual responses vary.
Outcomes in published case series include cognitive improvements for some participants. Formal independent large-scale randomized trials are still limited. The approach requires significant commitment and medical oversight.
Questions to ask a provider
1. What laboratory and cognitive testing is required to create a ReCODE/Bredesen plan, and what is the total cost? 2. How is the protocol personalized for my specific subtype or contributors to cognitive decline? 3. What lifestyle, dietary, and supplement changes will be expected, and how will adherence be supported? 4. What cognitive improvements have been documented in people with a profile similar to mine, and over what timeframe? 5. How will progress be monitored, and how does this approach integrate with my existing neurologist or primary care?
Website and contact information
Explore the interactive Treatment Database
Continue to compare educational treatment information in the interactive database. The standard disclaimer acknowledgement is required before the database opens.
Explore treatment information in the database